Announcements Statement by MassBio’s Chief of Corporate Affairs Zach Stanley on Senate Passage of Senate Bill 2651, An Act Relative to Pharmaceutical Access, Costs and Transparency Feb 10, 2022
Announcements MassBio’s® 2021 Massachusetts Biopharma Funding Report Reveals Another Record-Breaking Year for the Industry Jan 26, 2022
Announcements Application Now Open for the Inaugural Cohort of MassBio’s Next Generation Biotech Accelerator, MassBioDrive Jan 04, 2022
Announcements MassBio® Survey Establishes First-of-its-Kind, Massachusetts-Specific Biopharma Workforce Demographic Data Nov 17, 2021
Announcements Otsuka and MassBio Issue Call for Pathbreaking Innovation in CNS, Nephrology, and Autoimmune Disease Oct 07, 2021
